###begin article-title 0
Deleted in Liver Cancer 2 (DLC2) Was Dispensable for Development and Its Deficiency Did Not Aggravate Hepatocarcinogenesis
###end article-title 0
###begin p 1
Conceived and designed the experiments: TOY IOLN. Performed the experiments: TOY THYL SGSL OFC EKKT PLK AKML. Analyzed the data: TOY THYL EKKT PLK SC IOLN. Contributed reagents/materials/analysis tools: TOY THYL SC IOLN. Wrote the paper: TOY THYL IOLN.
###end p 1
###begin p 2
Current address: Department of Obstetrics and Gynecology, The University of Hong Kong, Hong Kong, China
###end p 2
###begin p 3
###xml 112 117 <span type="species:ncbi:9606">human</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
###xml 684 688 <span type="species:ncbi:10090">mice</span>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
###xml 796 800 <span type="species:ncbi:10090">mice</span>
###xml 926 931 <span type="species:ncbi:10090">mouse</span>
DLC2 (deleted in liver cancer 2), a Rho GTPase-activating protein, was previously shown to be underexpressed in human hepatocellular carcinoma and has tumor suppressor functions in cell culture models. We generated DLC2-deficient mice to investigate the tumor suppressor role of DLC2 in hepatocarcinogenesis and the function of DLC2 in vivo. In this study, we found that, unlike homologous DLC1, which is essential for embryonic development, DLC2 was dispensable for embryonic development and DLC2-deficient mice could survive to adulthood. We also did not observe a higher incidence of liver tumor formation or diethylnitrosamine (DEN)-induced hepatocarcinogenesis in DLC2-deficient mice. However, we observed that DLC2-deficient mice were smaller and had less adipose tissue than the wild type mice. These phenotypes were not due to reduction of cell size or defect in adipogenesis, as observed in the 190B RhoGAP-deficient mouse model. Together, these results suggest that deficiency in DLC2 alone does not enhance hepatocarcinogenesis.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
Hepatocellular carcinoma (HCC) is a primary malignancy and is one of the most common cancers in Asia and Africa. Infection with hepatitis B or C virus infection and exposure to aflatoxin B1 have been well documented as the major causes. However, the underlying molecular mechanisms leading to the development and progression of HCC remain unclear.
###end p 5
###begin p 6
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2</italic>
###xml 261 264 261 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Ching1">[1]</xref>
###xml 385 388 385 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Ching1">[1]</xref>
###xml 390 393 390 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Leung1">[2]</xref>
###xml 321 326 <span type="species:ncbi:9606">human</span>
Inactivation of tumor suppressor genes is a hallmark of cancer cells. In a quest for tumor suppressors involved in hepatocarcinogenesis, we identified a novel gene DLC2 (deleted in liver cancer 2) on chromosomal region 13q12.3, which is frequently lost in HCCs [1]. Similar to its homolog DLC1, DLC2 is underexpressed in human HCCs and has tumor suppressor functions in cultured cells [1], [2].
###end p 6
###begin p 7
###xml 119 122 119 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Ching1">[1]</xref>
###xml 124 127 124 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Yuan1">[3]</xref>
###xml 184 187 184 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Schultz1">[4]</xref>
###xml 189 192 189 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Li1">[5]</xref>
###xml 256 259 256 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Ponting1">[6]</xref>
###xml 261 264 261 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Ng1">[7]</xref>
###xml 444 447 444 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-BarSagi1">[8]</xref>
###xml 449 452 449 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Sahai1">[9]</xref>
###xml 670 674 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Qiu1">[10]</xref>
###xml 676 680 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Roux1">[11]</xref>
###xml 738 741 738 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Sahai1">[9]</xref>
DLC1 and DLC2 are Rho GTPase-activating proteins (GAPs). They have three functional domains, a catalytic RhoGAP domain [1], [3], a sterile alpha motif (SAM) protein interaction domain [4], [5] and a lipid-binding StAR-related lipid-transfer (START) domain [6], [7]. The Rho family GTPases have 18 members, including the three well-studied representatives, Rac1, RhoA, and Cdc42. These small GTPases regulate various cellular signaling pathways [8], [9]. It has been suggested that the Rho proteins play important roles in oncogenic transformation mediated by Ras and other oncoproteins by regulating actin cytoskeleton organization, cell proliferation and cell survival [10], [11]. Also, they stimulate tumor cell invasion and metastasis [9]. Rho GTPase-activating proteins (GAPs) inactivate them by converting the active GTP-bound state to the inactive GDP-bound one through activation of the intrinsic GTPase activity of Rho proteins. GAPs have therefore been suggested to be tumor suppressors which counteract the oncogenic potential of Rho proteins.
###end p 7
###begin p 8
###xml 133 136 133 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Ching1">[1]</xref>
###xml 138 141 138 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Leung1">[2]</xref>
###xml 143 146 143 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Yuan1">[3]</xref>
###xml 148 151 148 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Li1">[5]</xref>
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Ng2">[12]</xref>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Goodison1">[13]</xref>
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Healy1">[14]</xref>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Kim1">[15]</xref>
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Wong1">[16]</xref>
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Durkin1">[17]</xref>
###xml 504 508 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Sordella1">[18]</xref>
###xml 844 848 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Sordella2">[19]</xref>
###xml 359 364 <span type="species:ncbi:10090">mouse</span>
###xml 712 718 <span type="species:ncbi:10090">murine</span>
There have been several lines of in vitro evidence to support the tumor suppressor role of these two Rho GAP proteins, DLC1 and DLC2 [1], [2], [3], [5], [12], [13], [14], [15], [16]. Animal models which could be exploited to investigate the tumor suppressor functions of these two proteins are still limited. Durkin et al. [17] has generated a DLC1-deficient mouse model to study the biological functions of DLC1. However, the DLC1 deficiency leads to embryonic lethality by midgestation. Sordella et al [18] showed that embryos lacking p190B RhoGAP were about 30% smaller in size and provided evidence to suggest that this reduction in embryo size was due to reduction in cell size. They also demonstrated that murine embryonic fibroblasts derived from these embryos were defective in adipogenesis when compared with the wild type counterpart [19].
###end p 8
###begin p 9
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
###xml 571 577 <span type="species:ncbi:10090">murine</span>
In this study, we generated DLC2-deficient mice to investigate the biological functions of DLC2 and its role in hepatocarcinogenesis in vivo. Unlike the DLC1 knockout model, DLC2 was dispensable for embryonic development and DLC2-deficient mice could survive to adulthood. DLC2-deficient mice did not show higher incidence of hepatocarcinogenesis or diethylnitrosamine (DEN)-induced hepatocarcinogenesis. However, DLC2-deficient mice were significantly smaller and had less adipose tissue than the wild type mice. Analysis of adipogenesis of DLC2-deficient and wild type murine embryonic fibroblasts did not show significant difference between them. Also, we did not observe any significant difference in the cell size between G1 phase DLC2-deficient and wild type immortalized fibroblasts with flow cytometry.
###end p 9
###begin title 10
Materials and Methods
###end title 10
###begin title 11
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Generation of DLC2-deficient mice
###end title 11
###begin p 12
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dlc-2</italic>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dlc-2</italic>
###xml 180 183 180 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 245 248 245 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 251 254 251 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 271 280 271 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006566-g001">Figure 1a</xref>
###xml 459 468 459 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006566-g001">Figure 1a</xref>
###xml 510 514 510 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Tybulewicz1">[20]</xref>
###xml 557 560 557 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 826 830 826 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2</italic>
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
###xml 136 141 <span type="species:ncbi:10090">mouse</span>
A PAC clone containing the mouse Dlc-2 genomic region was obtained from the Sanger Centre (Cambridge, United Kingdom). To construct the mouse Dlc-2 gene targeting vector, a 2.8 kb EcoRI/BamHI fragment, which is 3' to exon 5, was cloned into the EcoRI/BamHI site of pPNT (Figure 1a). A pair of primers (forward, 5'-ttactcgagttgctgatgcacaggtcttc; reverse, 5'-ttactcgagttctcgtgttaggaatgggg) was used to amplify a genomic region, 2.7 kb in size and 5' to exon 5 (Figure 1a). The fragment was then cloned into pPNT [20]. The targeting vector was linearized with NotI and was electroporated into the AB2.2 embryonic stem (ES) cell line (129s7/SvEBrd-Hprt b-m2), and the cells were cultured in ES cell culture medium supplemented with G418 and fialuridine. Resistant clones were analyzed by Southern blotting (see below) to identify DLC2-targeted clones.
###end p 12
###begin title 13
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Gene targeting to generate DLC2-deficient mice.
###end title 13
###begin p 14
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
(a) Schematic diagram to show gene targeting strategy. Black boxes, exons of the mouse DLC2 gene (exon numbers are written at the top); gray boxes, DNA sequence of neomycin resistance gene of the targeting construct; white box, DNA sequence of thymidine kinase gene of the targeting construct. Restriction enzyme digestion sites: B, BamHI; Bg, BglII; E, EcoRI; N, NcoI; only diagnostic restriction sites are shown for simplicity. (b) Southern blot analysis. BglII digestion was probed with 5' probe as indicated; sizes of diagnostic bands: wild type allele, 4.7 kb; targeted allele, 5.7 kb. NcoI digestion was probed with 3' probe as indicated; sizes of diagnostic bands: wild type allele, 9.1 kb; targeted allele, 5.7 kb. (c) PCR genotyping; sizes of bands: wild type allele, 414 bp; targeted allele, 339 bp. (d) RT-PCR to detect DLC2 expression in heart, liver and skeletal muscle.
###end p 14
###begin p 15
###xml 288 292 288 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2</italic>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
###xml 326 330 <span type="species:ncbi:10090">Mice</span>
All research involving animal work was approved by the Committee on the Use of Live Animals in Teaching and Research (CULATA) of the University of Hong Kong. Cells from these clones were injected into C57BL/6N blastocysts. Chimeras were mated with C57BL/6N mice, and offspring containing DLC2-targeted allele were identified. Mice with mixed genetic backgrounds were back-crossed to C57BL/6N for at least five generations.
###end p 15
###begin title 16
Southern blot analysis, PCR genotyping and RT-PCR
###end title 16
###begin p 17
###xml 71 80 71 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006566-g001">Figure 1a</xref>
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bgl</italic>
###xml 235 237 235 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nc</italic>
For Southern blot analysis, two probes, 5' and 3' external, were used (Figure 1a). BglII digestion was probed with the 5' probe and the sizes of diagnostic bands were 4.7 kb for the wild type allele and 5.7 kb for the targeted allele. NcoI digestion was probed with the 3' probe, and the sizes of diagnostic bands were 9.1 kb for the wild type allele and 5.7 kb for the targeted allele.
###end p 17
###begin p 18
###xml 99 122 99 122 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AATGGAAGCACCATGTAGCC</named-content>
###xml 143 167 143 167 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- AATGGAAGCACCATGTAGCC</named-content>
###xml 273 296 273 296 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTGGGAAGACAGGGAACAAA</named-content>
###xml 319 342 319 342 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGGGGAACTTCCTGACTAGG</named-content>
Two pairs of primers were used for PCR genotyping. For detection of the wild type allele, forward (5'-AATGGAAGCACCATGTAGCC) and reverse primer 5'- AATGGAAGCACCATGTAGCC) were used, with expected size of the PCR product 414 bp. For detection of the targeted allele, forward (5'-CTGGGAAGACAGGGAACAAA) and reverse primers (5'-GGGGGAACTTCCTGACTAGG) were used, with expected size of the PCR product being, 339 bp.
###end p 18
###begin p 19
###xml 339 349 331 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC1, DLC2</italic>
###xml 354 358 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC3</italic>
###xml 398 402 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC1</italic>
###xml 423 452 415 444 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene"> (5&#8242;- CCCATTCAGTCAGTCCACCTTGA</named-content>
###xml 473 500 465 492 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene"> (5&#8242;- GAGTCTCCCTCGTCGGAAAAC</named-content>
###xml 523 527 515 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2</italic>
###xml 548 573 540 565 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene"> (5&#8242;-GATGAGAAACACAGCCAGCA</named-content>
###xml 593 618 585 610 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene"> (5&#8242;-GTTGGGTATCTGGACGCACT</named-content>
###xml 635 639 627 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC3</italic>
###xml 655 680 647 672 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene"> (5&#8242;-TCCACAGGCAGCCATGCCAG</named-content>
###xml 701 727 693 719 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene"> (5&#8242;-TCTTGCTCAAGATCCTGGGCC</named-content>
###xml 832 836 818 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC1</italic>
###xml 841 845 827 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2</italic>
###xml 861 865 847 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC3</italic>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 392 397 <span type="species:ncbi:10090">mouse</span>
###xml 517 522 <span type="species:ncbi:10090">mouse</span>
For semi-quantitative RT-PCR analysis, total RNA was prepared from mouse tissues using the TRIzol reagent (Invitrogen). First-strand cDNA was synthesized from 1 microg of total RNA using random hexamers with GeneAmp RNA PCR Kit (Applied Biosystems, Foster City, CA). Two microl of cDNA was then used for detecting the expression levels of DLC1, DLC2 and DLC3 using the following primers: For mouse DLC1 gene, forward primer (5'- CCCATTCAGTCAGTCCACCTTGA) and reversed primer (5'- GAGTCTCCCTCGTCGGAAAAC) were used; For mouse DLC2 gene, forward primer (5'-GATGAGAAACACAGCCAGCA) and reverse primer (5'-GTTGGGTATCTGGACGCACT) were used; For DLC3, forward primer (5'-TCCACAGGCAGCCATGCCAG) and reversed primer (5'-TCTTGCTCAAGATCCTGGGCC) were used. PCR condition was as follows: denaturation at 95degreesC for 15 min, followed by 25 cycles (DLC1 and DLC2) or 27 cycles (DLC3) of denaturation for 30 sec, annealing at 55degreesC for 30 sec with extension at 72degreesC for 30 sec and a final extension at 72degreesC for 10 min. PCR products were resolved in 1.2% agarose gel.
###end p 19
###begin title 20
Metabolic cage experiment
###end title 20
###begin p 21
###xml 95 105 95 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were individually housed in metabolic cages in a 12:12-hour dark-light cycle and were fed ad libitum. Water and food consumption, and urine and faeces output were measured for 2 days.
###end p 21
###begin title 22
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Diethylnitrosamine (DEN) treatment of mice
###end title 22
###begin p 23
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2</italic>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
The hepatocarcinogenesis protocol was as follows. The 15-day-old male DLC2 homozygous knockout mice and wild type mice were injected intraperitoneally with 25 mg/kg DEN in sterile PBS. At 35 weeks of age, mice were sacrificed and their livers were harvested and examined. The livers were then fixed in 4% formaldehyde in PBS, embedded in paraffin and cut into 4-microm sections for histological examination.
###end p 23
###begin title 24
###xml 15 21 <span type="species:ncbi:10090">murine</span>
Preparation of murine embryonic fibroblasts (MEFs) and establishment of cell lines
###end title 24
###begin p 25
###xml 610 614 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Todaro1">[21]</xref>
###xml 733 734 721 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 688 692 <span type="species:ncbi:9913">calf</span>
Pregnant mice were sacrificed at 13.5 days past coitus (dpc). The embryos were dissected from the uterus, and the extra-embryonic membranes and viscera were removed. The embryos were cut into small pieces, and soaked for 30 min in 4 ml of 0.25% trypsin-EDTA at room temperature. Trypsinization was inactivated with alpha-modified Eagle medium (alphaMEM) supplemented with 10% heat-inactivated FBS, 50 U of penicillin per ml, and 50 microg of streptomycin per ml. The cells were suspended by pipetting and passed through a strainer. Standard procedures were used to establish immortalized fibroblast cell lines [21]. Briefly, cells were passaged every 3 days in DMEM supplemented with 10% calf serum and antibiotics at a density of 106 cells per 10 cm dish. Media were changed on the subsequent day. Stable immortalized cell lines were established after 30 to 50 passages.
###end p 25
###begin title 26
Measurement of cell sizes
###end title 26
###begin p 27
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>+/+</sup></italic>
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
The relative sizes of DLC2+/+ and DLC2-/- cells were determined with flow cytometry. Briefly, cells were BrdU-labeled using FITC BrdU Flow Kit (BD Pharmingentrade mark, NJ, USA). G1 population of cells was gated and the forward light scatter (FSC) of 5000 G1-cells was determined. FSC was used to determine the relative cell sizes.
###end p 27
###begin title 28
Induction of adipocyte differentiation
###end title 28
###begin p 29
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Sordella2">[19]</xref>
For induction of adipocyte differentiation, MEF cells used were within two passages. Induction of adipocyte differentiation was performed as previously described [19]. Cells were cultured on 6-well plates and propagated to confluence. Two days later, the medium was replaced with standard differentiation induction medium (alpha-MEM containing 0.5 mM isobutylmethylxanthine, 1 microM dexamethasone, 5 microg of insulin per ml, 10% FBS, 50 U of penicillin per ml, and 50 microg of streptomycin per ml, and the medium was renewed every other day. The cells were induced for 8 days before analysis.
###end p 29
###begin p 30
The cells were fixed in 10% formalin, rinsed twice with phosphate-buffered saline (PBS), and stained with Oil-Red O staining solution (0.5% Oil-Red O in isopropyl alcohol solution-distilled water [60:40]) for 30 min at 37degreesC and then washed with distilled water three times. Adipogenesis in Oil-Red-O-stained MEF was quantified by measuring the absorbance of light at 510 nM after extraction with isopropyl alcohol.
###end p 30
###begin title 31
Rhotekin binding assay
###end title 31
###begin p 32
Cells were lysed in 500 microl of lysis buffer containing 50 mM Tris (pH 7.4), 10 mM MgCl2, 500 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% sodium deoxycholate, 10 microg/ml of aprotinin, 10 microg/ml of leupeptin, and 1 mM PMSF. The lysates were cleared by centrifugation at 12,000 x g for 10 min at 4degreesC, and 500 microg of each lysate was incubated with 45 microg of GST-RBD (GST fusion protein containing RhoA-binding domain of Rhotekin) bound to glutathione-Sepharose beads (Amersham Pharmacia) for 1 h. After binding, the samples were washed with lysis buffer for three times. Bound proteins were fractionated on 12% SDS/PAGE and immunoblotted with polyclonal antibody for RhoA (Santa Cruz Biotechnology). Total cell lysate was also analyzed with anti-RhoA antibody as a loading control. The level of active RhoA was determined after normalization with the total RhoA present in the cell lysates.
###end p 32
###begin title 33
Immunofluorescence staining
###end title 33
###begin p 34
###xml 208 214 <span type="species:ncbi:9913">bovine</span>
Cells were grown on cover slips and were rinsed in PBS, fixed with 4% paraformaldehyde in PBS for 15 minutes at room temperature, permeabilized with 0.5% Triton X-100 in PBS for 5 minutes and blocked with 5% bovine serum albumin in PBS. After washing with PBS, cells were then incubated with paxillin antibody (Sigma), followed by FITC-conjugated secondary antibody at room temperature. F-actins were stained with tetramethylrhodamine B isothiocyanate-labeled phalloidin (Sigma) for 20 min at room temperature, and the nuclei were stained by DAPI. Cells were mounted with Vectashield antifade solution (Vector Laboratories).
###end p 34
###begin title 35
Results
###end title 35
###begin title 36
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Generation of DLC2-deficient mice
###end title 36
###begin p 37
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 273 277 273 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2</italic>
###xml 354 363 354 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006566-g001">Figure 1a</xref>
###xml 437 453 437 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006566-g001">Figure 1b and 1c</xref>
###xml 460 463 460 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 456 463 456 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 489 493 489 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2</italic>
###xml 576 585 576 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006566-g001">Figure 1d</xref>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 136 141 <span type="species:ncbi:10090">mouse</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
To study the function of the DLC2 in vivo and the role of DLC2 in hepatocarcinogenesis, we generated DLC2-deficent mice. Disruption the mouse DLC2 gene was achieved by homologous recombination in embryonic stem (ES) cells. In the recombination, exon 5, the largest exon of DLC2 gene, was replaced by the neomycin resistance gene of the targeting vector (Figure 1a). Two targeted ES clones were used to establish the DLC2-deficient mice (Figure 1b and 1c). DLC2-/- mice did not express the DLC2 mRNA as detected by RT-PCR on selected tissues, heart, liver and skeletal muscle (Figure 1d).
###end p 37
###begin title 38
###xml 15 19 <span type="species:ncbi:10090">mice</span>
DLC2-deficient mice were anatomically normal but smaller and had less adipose fat
###end title 38
###begin p 39
###xml 15 18 15 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 11 18 11 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC1<sup>&#8722;/&#8722;</sup></italic>
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 56 63 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 199 202 199 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 195 202 195 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 250 253 250 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 246 253 246 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 314 323 314 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006566-g002">Figure 2a</xref>
###xml 385 399 385 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006566-g002">Figure 2b &amp; 2c</xref>
###xml 448 451 448 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 444 451 444 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 486 489 486 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 482 489 482 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>+/+</sup></italic>
###xml 773 776 773 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 769 776 769 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 790 793 790 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 786 793 786 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>+/+</sup></italic>
###xml 800 808 800 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006566-g003">Figure 3</xref>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 777 781 <span type="species:ncbi:10090">mice</span>
###xml 794 798 <span type="species:ncbi:10090">mice</span>
Unlike the DLC1-/- mice, which died in embryonic stage, DLC2-/- mice could survive to adulthood. This suggests that DLC2 is dispensable for embryonic development. Anatomical analysis showed that DLC2-/- mice were normal (at 30 week-old), however DLC2-/- mice were smaller in size and lighter in weight (p = 0.01) (Figure 2a) and had less adipose tissue than wild type mice (p = 0.02) (Figure 2b & 2c). We wanted to exclude the possibility that DLC2-/- mice might eat less food than DLC2+/+ mice and this might contribute to their smaller body size. We therefore performed metabolic cage experiment to investigate whether there were any differences in food and water consumption. However, we could not detect any significant differences in food and water intake between DLC2-/- mice and DLC2+/+ mice (Figure 3).
###end p 39
###begin title 40
###xml 15 19 <span type="species:ncbi:10090">mice</span>
DLC2-dificient mice were smaller and had less adipose fat.
###end title 40
###begin p 41
(a) Body weight. (b) Weight of epididymal fat pads. In (a) and (b), mean values+/-standard errors and p-values are shown. P-values were calculated by unpaired Student's t test. (c) Representative samples of epididymal fat pads.
###end p 41
###begin title 42
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Food and water intake in DLC2+/+ and DLC2-/- mice.
###end title 42
###begin p 43
(a) Food intake, (b) water intake, (c) feces output and (d) urine output in 24 hours. Mean values+/-standard errors and p-values are shown. P-values were calculated by unpaired Student's t test.
###end p 43
###begin title 44
Depletion of DLC2 did not affect cell size and adipogenesis in MEFs
###end title 44
###begin p 45
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Sordella1">[18]</xref>
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Sordella2">[19]</xref>
###xml 372 375 372 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 368 375 368 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
###xml 376 381 <span type="species:ncbi:10090">mouse</span>
The p190B RhoGAP-deficient mouse embryos were smaller than the wild type embryos and fibroblasts derived from the p190B RhoGAP-deficient embryos were smaller than those derived from wild type embryos [18]. Also, fibroblasts derived from the p190B RhoGAP-deficient embryos were defective in adipogenesis [19]. We therefore examined whether fibroblasts derived from the DLC2-/- mouse embryos were smaller in size and defective in adipogenesis.
###end p 45
###begin p 46
###xml 80 83 80 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 76 83 76 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 151 154 151 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 147 154 147 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>+/+</sup></italic>
###xml 170 186 170 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006566-g004">Figure 4a and 4b</xref>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Sordella1">[18]</xref>
###xml 443 446 443 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 439 446 439 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 455 458 455 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 451 458 451 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>+/+</sup></italic>
###xml 537 546 537 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006566-g004">Figure 4c</xref>
###xml 727 730 727 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Leung1">[2]</xref>
###xml 782 785 782 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 778 785 778 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 810 819 810 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006566-g004">Figure 4d</xref>
###xml 949 952 949 952 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 945 952 945 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 961 964 961 964 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 957 964 957 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>+/+</sup></italic>
###xml 972 981 972 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006566-g004">Figure 4e</xref>
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
###xml 155 160 <span type="species:ncbi:10090">mouse</span>
###xml 459 464 <span type="species:ncbi:10090">mouse</span>
As demonstrated with flow cytometry, the size of the cells derived from the DLC2-/- mouse embryos was not significantly different from that of the DLC2+/+ mouse embryos (Figure 4a and 4b). Since Sordella et al. [18] showed the AKT pathway was downstream target of RhoA, and this eventually led to the decreased cell size of fibroblasts derived from the p190B RhoGAP-deficient embryos, we examined the AKT pathway in cells derived from the DLC2-/- and DLC2+/+ mouse embryos. We did not detect any difference between them in this pathway (Figure 4c). We previously showed that DLC2 was a RhoGAP; overexpression of DLC2 down-regulated Rho activity in hepatoma cell lines and resulted in inhibition of actin stress fiber formation [2]. However, up-regulation of Rho activity in the DLC2-/- cells was not observed (Figure 4d) and there was some slight but not significant difference in the formation of actin stress fibers or focal adhesions between DLC2-/- and DLC2+/+ cells (Figure 4e). These suggest that there might be other functionally similar proteins which could compensate the function of DLC2.
###end p 46
###begin title 47
Depletion of DLC2 does not affect cell sizes.
###end title 47
###begin p 48
(a) Comparison of sizes of DLC2+/+ (n = 6) and DLC2-/- (n = 6) cells by flow cytometry. Forward light scatter (FSC) of G1-phase-cells as determined by flow cytometry was used to measure the relative cell sizes. Mean values+/-standard errors and p-values are shown. P-values were calculated by unpaired Student's t test. (b) Representative samples of flow cytometry results. (c) Western blot analysis of insulin-treated DLC2+/+ and DLC2-/- cells. (d) RhoA activity of DLC2+/+ and DLC2-/- cells as detected by Rhotekin binding assay. (e) Actin cytoskeleton and focal adhesions in DLC2+/+ and DLC2-/- MEF cells were detected by immunofluorescence staining of actin stress fibers (red) and Paxillin (green), respectively.
###end p 48
###begin p 49
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 78 81 78 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 74 81 74 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>+/+</sup></italic>
###xml 106 109 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 102 109 102 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 118 121 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 114 121 114 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>+/+</sup></italic>
###xml 206 208 206 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/</sup>
###xml 202 208 202 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/</sup></italic>
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 218 221 218 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 214 221 214 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>+/+</sup></italic>
###xml 345 353 345 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006566-g005">Figure 5</xref>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
We then examined adipogenesis in fibroblasts derived from the DLC2-/- and DLC2+/+ mouse embryos. When DLC2-/- and DLC2+/+ cells were induced by standard adipocyte differentiation induction medium, both DLC2-/- and DLC2+/+ cells were competent to differentiate into adipocytes and did not significantly differ in lipid production quantitatively (Figure 5).
###end p 49
###begin title 50
Depletion of DLC2 does not affect adipogenesis in MEFs.
###end title 50
###begin p 51
(a) Induction of adipogenesis was performed on DLC2-/- (n = 6) and DLC2+/+ (n = 6) MEFs. After induction, MEFs were stained with Oil-Red O, and the stain was then extracted and absorbance at 510 nm was measured. Mean values+/-standard errors and p-values are shown. P-values were calculated by unpaired Student's t test. (b) Representative samples of Oil-Red O-stained MEFs.
###end p 51
###begin title 52
Depletion of DLC2 did not predispose to the formation of liver tumors nor aggravate DEN-induced hepatocarcinogenesis
###end title 52
###begin p 53
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 66 73 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 211 214 211 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 207 214 207 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 223 226 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 219 226 219 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>+/+</sup></italic>
###xml 533 536 533 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 529 536 529 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 545 548 545 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 541 548 541 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>+/+</sup></italic>
###xml 589 597 589 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006566-g006">Figure 6</xref>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 251 255 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
We did not observe any tumor formation in the livers of the adult DLC2-/- mice up to an age of 18 months. To address the role of DLC2 in chemical-induced hepatocarcinogenesis, we treated the 15-day old male DLC2-/- and DLC2+/+ mice with DEN. When the mice reached 35 weeks of age, they were dissected and their livers were examined for tumor formation. We observed that liver tumors developed in all of the mice treated with DEN. In addition, the numbers of tumors formed and the maximal tumor diameters were similar in both the DLC2-/- and DLC2+/+ mice (p = 0.79 and 0.51, respectively) (Figure 6). These findings suggest that DLC2 deficiency does not aggravate chemical hepatocarcinogenesis.
###end p 53
###begin title 54
Depletion of DLC2 did not aggravate DEN-induced hepatocarcinogenesis.
###end title 54
###begin p 55
(a) Number of tumors formed in livers after DEN treatment. (b) Size of tumor as represented by maximum diameter (in millimeters). In (a) and (b), mean values+/-standard errors and p-values are shown. P-values were calculated by unpaired Student's t test. (c) Representative liver samples treated with DEN. White arrows indicate tumors. (d) Representative H&E stained sections of liver samples treated with DEN.
###end p 55
###begin title 56
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC1</italic>
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC3</italic>
DLC1 and DLC3 mRNA expression in DLC2-depleted tissues
###end title 56
###begin p 57
###xml 113 116 113 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 109 116 109 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 125 128 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 121 128 121 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>+/+</sup></italic>
###xml 225 228 225 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 221 228 221 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 326 329 326 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 322 329 322 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 350 359 350 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006566.s001">Figure S1</xref>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
Semi-quantitative PCR was performed on selected tissues including livers, skeletal muscles and hearts of the DLC2-/- and DLC2+/+ mice at 3 months of age to observe any gene dosage compensation by other DLC members in our DLC2-/- mice. Our data showed no significant increase of either DLC1 or DLC3 in those tissues of the DLC2-/- mice (Supplementary Figure S1). The experiments were performed independently thrice.
###end p 57
###begin title 58
Discussion
###end title 58
###begin p 59
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Durkin1">[17]</xref>
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Durkin1">[17]</xref>
###xml 310 314 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Wong2">[22]</xref>
###xml 438 442 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Wei1">[23]</xref>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Zhao1">[24]</xref>
###xml 695 701 <span type="species:ncbi:10090">murine</span>
It was reported that DLC1-deficient embryos had neural tube defects and died at early to midgestation [17]. As suggested by Durkin et al. [17], this might also be due to the primary malfunction of other organs such as the developing heart. Our group recently showed that DLC1 negatively regulated the Rho/ROCK [22]. Also, a relatively high level of ROCK expression was previously observed in the developing hearts of embryos, 7.0-9.0 dpc [23] and 9.5-11.5 dpc [24]. This suggests that DLC1 deficiency may disturb the normal function of ROCK proteins in the embryonic heart and lead to embryonic lethality. Nevertheless, the observed phenotypes suggest that DLC1 has a critical role during early murine development.
###end p 59
###begin p 60
###xml 534 538 534 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Manley1">[25]</xref>
###xml 540 544 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Manley2">[26]</xref>
###xml 773 777 773 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Sordella1">[18]</xref>
###xml 818 822 818 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Sordella2">[19]</xref>
###xml 994 997 994 997 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 990 997 990 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 1006 1009 1006 1009 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1002 1009 1002 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>+/+</sup></italic>
###xml 1106 1109 1106 1109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1102 1109 1102 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 1118 1121 1118 1121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1114 1121 1114 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>+/+</sup></italic>
###xml 1405 1408 1405 1408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1401 1408 1401 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>&#8722;/&#8722;</sup></italic>
###xml 1471 1474 1471 1474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1467 1474 1467 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLC2<sup>+/+</sup></italic>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 394 399 <span type="species:ncbi:10090">mouse</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 855 859 <span type="species:ncbi:10090">mice</span>
###xml 1010 1014 <span type="species:ncbi:10090">mice</span>
###xml 1122 1126 <span type="species:ncbi:10090">mice</span>
###xml 1409 1413 <span type="species:ncbi:10090">mice</span>
###xml 1475 1479 <span type="species:ncbi:10090">mice</span>
In this study, we showed that DLC2 deficiency did not cause any observable developmental defects, and DLC2-deficient mice could survive to adulthood. This suggests that the functions of DLC2 in embryonic development may be compensated by its homolog, DLC1, but not vice versa. It is common that paralogous genes compensate the functions of the members of the group. For example, the members of mouse Hox paralogous group 3, Hoxa3, Hoxb3 and Hoxd3, interact synergistically to regulate embryonic development in a dose-dependant manner [25], [26]. Although DLC2 deficiency did not lead to embryonic lethality, DLC2-deficient mice were smaller and had less adipose tissue. Since it was demonstrated that the fibroblasts derived from 190B RhoGAP-deficient embryos were smaller [18] and were less effective in adipogenesis [19], we examined the DLC2-deficient mice along these lines. However, we observed no significant differences in cell size and adipogenesis between fibroblasts derived from DLC2-/- and DLC2+/+ mice. Also, the metabolic cage experiment did not detect any significant difference between DLC2-/- and DLC2+/+ mice. In this regard, we could not exclude the possibility that the metabolic cage experiment might not be sensitive enough to detect the small difference in the amount of food intake which may cause the observed phenotype in body weight. Also we could not exclude the fact that DLC2-/- mice might be more active and consumed more calories than DLC2+/+ mice.
###end p 60
###begin p 61
###xml 101 104 101 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Ng1">[7]</xref>
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Stocco1">[27]</xref>
It was demonstrated that DLC2 localized in the mitochondria and might play a role in lipid transport [7]. In addition, it has been suggested that the START domain containing protein, StAR, is an essential component in steroid hormone production in translocation of the cholesterol from the outer membrane to the inner membrane of the mitochondria in steroidogenic cell [27]. Since DLC2 is a START domain containing protein and is able to localize in the mitochondria, it will be of interest to study the physiological function of DLC2 in relation with the lipid metabolism as well as steroid hormone biosynthesis.
###end p 61
###begin p 62
###xml 43 46 43 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Ching1">[1]</xref>
###xml 48 51 48 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Leung1">[2]</xref>
###xml 53 57 53 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Xiaorong1">[28]</xref>
###xml 201 204 201 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Ching1">[1]</xref>
###xml 206 209 206 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Leung1">[2]</xref>
###xml 914 918 914 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Klocke1">[29]</xref>
###xml 1113 1117 1113 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-SantoniRugiu1">[30]</xref>
###xml 1264 1268 1264 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Zender1">[31]</xref>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 559 563 <span type="species:ncbi:10090">mice</span>
###xml 682 686 <span type="species:ncbi:10090">mice</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
###xml 877 892 <span type="species:ncbi:10090">transgenic mice</span>
###xml 968 972 <span type="species:ncbi:10090">mice</span>
###xml 993 997 <span type="species:ncbi:10090">mice</span>
###xml 1044 1059 <span type="species:ncbi:10090">transgenic mice</span>
DLC2 was shown to be underexpressed in HCC [1], [2], [28] and have tumor suppressor functions including suppression of cell proliferation, Ras-induced colony formation and anchorage-independent growth [1], [2]. One of our primary aims in generating the DLC2-deficient mice was to investigate the tumor suppressor role of DLC2 in vivo. We found that DLC2 deficiency did not predispose to the formation of HCC nor aggravate DEN-induced hepatocarcinogenesis. Again, the tumor suppressor function of DLC2 function may be compensated by DLC1. Since DLC1-deficient mice dies at embryonic stage, it would be interesting to see if hepatocyte-specific deficiency of DLC1 may predispose such mice to the development of HCC and to delineate the role of DLC2 deficiency in the development of HCC in these mice. It was demonstrated that loss of p53 would accelerate hepatocarcinogenesis in transgenic mice overexpressing c-myc [29]. It would be informative to cross DLC2-deficient mice with other knockout mice of tumor suppressor genes, such as p53 and/or transgenic mice overexpressing oncogenes such as c-myc and TGF-alpha [30]. Alternatively, the newly developed system by Zender et al. could be exploited to study the tumor suppressor role of DLC2 in hepatocarcinogenesis [31]. In that system, p53-deficient liver progenitor cells could be infected with a combination of ecotropic retroviruses carrying c-myc, RAS, AKT and DLC2. This will enable us to further investigate whether DLC2 has tumor suppressor function in vivo.
###end p 62
###begin p 63
###xml 509 513 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Kawai1">[32]</xref>
###xml 655 660 <span type="species:ncbi:10090">mouse</span>
###xml 728 732 <span type="species:ncbi:10090">mice</span>
###xml 1035 1039 <span type="species:ncbi:10090">mice</span>
###xml 1223 1227 <span type="species:ncbi:10090">mice</span>
###xml 1379 1383 <span type="species:ncbi:10090">mice</span>
DLC2 belongs to a member of DLC family proteins. It encodes a RhoGAP domain with high sequence homology with DLC family members, DLC1 and DLC3. In our previous studies, we demonstrated that DLC2 or DLC1 was able to inhibit the RhoA activity which resulted in down regulation of actin stress fiber formation. Furthermore, study from Kawai et al indicated that DLC3 could also inhibit the RhoA activity by its RhoGAP domain. Ectopic expression of DLC3 in HeLa cells decreased the numbers of actin stress fibers [32]. The results suggest that the functional roles of DLC1, DLC2 and DLC3 in cell lines and their downstream effectors are quite similar. In the mouse model, DLC1 depletion was embryonic lethal while our DLC2 knockout mice could survive to adulthood. This suggests that the functions of DLC2 in embryonic development may be compensated by DLC1 or DLC3. However, from our semi-quantitative RT-PCR result, there was no significant increase of either DLC1 or DLC3 in the livers, hearts and skeletal muscles of the DLC2 knockout mice. The result implies that the physiological level of DLC1 or DLC3 expression may be sufficient for the compensation of DLC2 functions. It will be interesting to generate DLC3 knockout mice to study its significance in embryonic development and examine whether its function can be compensated by other DLC members. In addition, the knockout mice data indicate that the DLC members might play different physiological roles in development. Apart from the common downstream effector (RhoA), there might be other different molecular targets being specifically regulated by a particular DLC member.
###end p 63
###begin p 64
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006566-Ullmannova1">[33]</xref>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Apart from studying the tumor suppressor role of DLC2 in HCC, the DLC2-deficient mice may be useful for studying other cancer types, as downregulation of DLC2 was also observed in lung, ovarian, renal, breast, uterine, gastric, colon and rectal cancers [33].
###end p 64
###begin title 65
Supporting Information
###end title 65
###begin p 66
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
Expression level of DLC1 and DLC3 in DLC2-/- and DLC2+/+ mice. Semi-quantitative PCR performed on the livers, skeletal muscles and hearts of the DLC2-/- and DLC2+/+ mice of 3 months of age showed no significant difference in the mRNA expression levels of DLC1 and DLC3. beta-actin gene was used for normalization.
###end p 66
###begin p 67
(0.39 MB TIF)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin title 69
References
###end title 69
###begin article-title 70
Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma.
###end article-title 70
###begin article-title 71
Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity.
###end article-title 71
###begin article-title 72
###xml 88 93 <span type="species:ncbi:9606">human</span>
###xml 129 132 <span type="species:ncbi:10116">rat</span>
Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP.
###end article-title 72
###begin article-title 73
SAM as a protein interaction domain involved in developmental regulation.
###end article-title 73
###begin article-title 74
Solution structures, dynamics, and lipid-binding of the sterile alpha-motif domain of the deleted in liver cancer 2.
###end article-title 74
###begin article-title 75
START: a lipid-binding domain in StAR, HD-ZIP and signalling proteins.
###end article-title 75
###begin article-title 76
Mitochondrial targeting of growth suppressor protein DLC2 through the START domain.
###end article-title 76
###begin article-title 77
Ras and Rho GTPases: a family reunion.
###end article-title 77
###begin article-title 78
RHO-GTPases and cancer.
###end article-title 78
###begin article-title 79
An essential role for Rac in Ras transformation.
###end article-title 79
###begin article-title 80
The small GTPases Cdc42Hs, Rac1 and RhoG delineate Raf-independent pathways that cooperate to transform NIH3T3 cells.
###end article-title 80
###begin article-title 81
DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1.
###end article-title 81
###begin article-title 82
The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells.
###end article-title 82
###begin article-title 83
DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms.
###end article-title 83
###begin article-title 84
###xml 112 117 <span type="species:ncbi:9606">human</span>
DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma.
###end article-title 84
###begin article-title 85
Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.
###end article-title 85
###begin article-title 86
DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development.
###end article-title 86
###begin article-title 87
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
Modulation of CREB activity by the Rho GTPase regulates cell and organism size during mouse embryonic development.
###end article-title 87
###begin article-title 88
Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis.
###end article-title 88
###begin article-title 89
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene.
###end article-title 89
###begin article-title 90
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines.
###end article-title 90
###begin article-title 91
Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma.
###end article-title 91
###begin article-title 92
Rho kinases play an obligatory role in vertebrate embryonic organogenesis.
###end article-title 92
###begin article-title 93
Rho-associated kinases play an essential role in cardiac morphogenesis and cardiomyocyte proliferation.
###end article-title 93
###begin article-title 94
Hox group 3 paralogous genes act synergistically in the formation of somitic and neural crest-derived structures.
###end article-title 94
###begin article-title 95
Hox group 3 paralogs regulate the development and migration of the thymus, thyroid, and parathyroid glands.
###end article-title 95
###begin article-title 96
StAR protein and the regulation of steroid hormone biosynthesis.
###end article-title 96
###begin article-title 97
Underexpression of deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma.
###end article-title 97
###begin article-title 98
###xml 48 63 <span type="species:ncbi:10090">transgenic mice</span>
Lack of p53 accelerates hepatocarcinogenesis in transgenic mice constitutively overexpressing c-myc in the liver.
###end article-title 98
###begin article-title 99
###xml 113 128 <span type="species:ncbi:10090">transgenic mice</span>
Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
###end article-title 99
###begin article-title 100
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.
###end article-title 100
###begin article-title 101
START-GAP3/DLC3 is a GAP for RhoA and Cdc42 and is localized in focal adhesions regulating cell morphology.
###end article-title 101
###begin article-title 102
Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors.
###end article-title 102
###begin p 103
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 103
###begin p 104
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The study was funded by Hong Kong Research Grants Council General Research Fund (HKU 7436/04M) and RGC Collaborative Research Fund (HKU 1/06C). I.O.L. Ng is Loke Yew Professor in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 104

